HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mu-Kuan Chen Selected Research

dehydroandrographolide

1/2017Correction: Dehydroandrographolide, an iNOS inhibitor, extracted from Andrographis paniculata (Burm.f.) Nees, induces autophagy in human oral cancer cells.
1/2017Dehydroandrographolide inhibits oral cancer cell migration and invasion through NF-κB-, AP-1-, and SP-1-modulated matrix metalloproteinase-2 inhibition.
10/2015Dehydroandrographolide, an iNOS inhibitor, extracted from Andrographis paniculata (Burm.f.) Nees, induces autophagy in human oral cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mu-Kuan Chen Research Topics

Disease

72Neoplasms (Cancer)
05/2022 - 10/2002
61Mouth Neoplasms (Oral Cancer)
01/2022 - 04/2010
25Squamous Cell Carcinoma of Head and Neck
05/2022 - 07/2011
21Nasopharyngeal Carcinoma
06/2022 - 10/2002
19Neoplasm Metastasis (Metastasis)
09/2021 - 12/2008
11Carcinogenesis
08/2020 - 11/2010
7Head and Neck Neoplasms (Head and Neck Cancer)
09/2021 - 11/2010
7Hepatocellular Carcinoma (Hepatoma)
04/2019 - 07/2010
5Lymphatic Metastasis
06/2019 - 03/2011
5Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
04/2018 - 03/2015
4Lung Neoplasms (Lung Cancer)
01/2017 - 01/2014
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2022 - 01/2013
3Carcinoma (Carcinomatosis)
09/2019 - 11/2010
2Infections
07/2020 - 07/2020
2COVID-19
07/2020 - 07/2020
2Blister (Bulla)
03/2018 - 01/2016
2Liver Neoplasms (Liver Cancer)
04/2016 - 06/2014
2Hypoxia (Hypoxemia)
01/2016 - 02/2015
2Genetic Predisposition to Disease (Genetic Predisposition)
11/2015 - 01/2012
2Allergic Rhinitis
03/2009 - 02/2005
1Papillomavirus Infections
03/2022

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
03/2022 - 12/2010
13Proteins (Proteins, Gene)FDA Link
05/2021 - 10/2004
9Environmental CarcinogensIBA
01/2019 - 03/2011
8Messenger RNA (mRNA)IBA
05/2022 - 11/2009
8p38 Mitogen-Activated Protein KinasesIBA
01/2020 - 10/2014
7Mitogen-Activated Protein KinasesIBA
08/2021 - 06/2015
6Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2020 - 01/2013
5Antineoplastic Agents (Antineoplastics)IBA
09/2019 - 01/2014
4CaspasesIBA
03/2018 - 02/2013
4pterostilbeneIBA
01/2017 - 01/2014
3Cadherins (E-Cadherin)IBA
05/2021 - 03/2012
3coronarin DIBA
08/2020 - 12/2017
3Vincristine (Oncovin)FDA LinkGeneric
03/2020 - 04/2015
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2020 - 09/2019
3Matrix Metalloproteinases (MMPs)IBA
01/2020 - 03/2010
3Cisplatin (Platino)FDA LinkGeneric
01/2020 - 01/2012
3PhytochemicalsIBA
01/2020 - 02/2013
3Tissue Inhibitor of Metalloproteinase-3IBA
10/2019 - 11/2015
3celastrolIBA
05/2019 - 08/2017
3Biological ProductsIBA
03/2019 - 11/2009
3Pharmaceutical PreparationsIBA
02/2019 - 01/2013
3polyphyllin VIIIBA
01/2018 - 10/2016
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2017 - 06/2014
3dehydroandrographolideIBA
01/2017 - 10/2015
3AntioxidantsIBA
06/2015 - 01/2014
3Docetaxel (Taxotere)FDA Link
06/2014 - 01/2012
3A-factor (Streptomyces)IBA
01/2013 - 08/2010
2luteolin-7-glucosideIBA
10/2021 - 01/2020
2AlkaloidsIBA
09/2021 - 09/2014
2dehydrocrenatidineIBA
09/2021 - 05/2021
2CateninsIBA
05/2021 - 02/2015
2Caspase 3 (Caspase-3)IBA
05/2021 - 12/2016
2Caspase 8 (Caspase-8)IBA
05/2021 - 04/2019
2Insulin-Like PeptidesIBA
08/2020 - 07/2010
2Fluorouracil (Carac)FDA LinkGeneric
08/2020 - 01/2012
2Transcription Factors (Transcription Factor)IBA
06/2020 - 09/2015
2tricetinIBA
01/2020 - 11/2017
2FlavonoidsIBA
01/2020 - 01/2020
2TriterpenesIBA
05/2019 - 08/2017
2Death Domain ReceptorsIBA
04/2019 - 08/2017
2NucleotidesIBA
01/2019 - 11/2012
2pinostilbeneIBA
01/2019 - 01/2018
2TegafurIBA
12/2018 - 07/2018
2UracilIBA
12/2018 - 07/2018
2hispolonIBA
01/2018 - 10/2014
2MicroRNAs (MicroRNA)IBA
01/2017 - 01/2012
2Cysteine (L-Cysteine)FDA Link
01/2017 - 07/2011
2glabridinIBA
04/2016 - 06/2014
2Cathepsin BIBA
01/2016 - 12/2012
2Carbonic Anhydrase IXIBA
01/2016 - 09/2014
2Small Interfering RNA (siRNA)IBA
01/2016 - 01/2014
2PolyphenolsIBA
10/2014 - 01/2013
2Carbonic Anhydrases (Carbonic Anhydrase)IBA
09/2014 - 08/2012
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
06/2014 - 01/2013
2Interleukin-6 (Interleukin 6)IBA
08/2013 - 01/2012
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2011 - 12/2010
2Plasminogen Activators (Plasminogen Activator)IBA
03/2011 - 12/2010
2Glutathione (Reduced Glutathione)IBA
09/2010 - 08/2010
2Glutathione Transferase (Glutathione S-Transferase)IBA
09/2010 - 08/2010
2TransferasesIBA
09/2010 - 08/2010
1xanthohumolIBA
06/2022
1Heme (Haem)IBA
05/2022
1picrasidine IIBA
05/2022
1Indicators and Reagents (Reagents)IBA
03/2022
1Aldehyde DehydrogenaseIBA
01/2022
1Genetic Markers (Genetic Marker)IBA
01/2022
1Lysine (L-Lysine)FDA Link
01/2022
1MethyltransferasesIBA
01/2022
1norharmanIBA
09/2021
1Heme Oxygenase-1IBA
08/2021

Therapy/Procedure

10Therapeutics
06/2021 - 02/2005
9Drug Therapy (Chemotherapy)
06/2021 - 10/2002
5Radiotherapy
06/2021 - 10/2002
3Chemoradiotherapy
07/2018 - 04/2008
2Chemoprevention
10/2015 - 01/2013
2Endoscopes
04/2015 - 08/2014
2Local Anesthesia
03/2009 - 02/2005
2Semiconductor Lasers
03/2009 - 02/2005
2Ambulatory Surgical Procedures (Outpatient Surgery)
03/2009 - 02/2005